TrialMedicine2015

Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial.

Ji-Young Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.